Stericycle (NASDAQ:SRCL) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Stericycle (NASDAQ:SRCL - Get Free Report) posted its quarterly earnings results on Thursday. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03, Briefing.com reports. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The firm had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same period in the prior year, the firm posted $0.49 earnings per share. The company's quarterly revenue was down 2.8% compared to the same quarter last year. Stericycle updated its FY 2024 guidance to 2.200-2.500 EPS.

Stericycle Stock Performance

NASDAQ SRCL traded down $0.20 during trading hours on Friday, hitting $46.31. The company's stock had a trading volume of 802,019 shares, compared to its average volume of 467,025. The company has a market cap of $4.30 billion, a P/E ratio of -192.95, a price-to-earnings-growth ratio of 2.68 and a beta of 1.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.94 and a quick ratio of 0.94. The company's 50 day simple moving average is $51.42 and its two-hundred day simple moving average is $48.15. Stericycle has a 12 month low of $37.78 and a 12 month high of $57.06.

Wall Street Analyst Weigh In

Several equities analysts recently commented on SRCL shares. Robert W. Baird decreased their price target on shares of Stericycle from $62.00 to $55.00 and set a "neutral" rating on the stock in a research note on Friday. Stifel Nicolaus raised their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a "buy" rating in a report on Thursday, February 29th. StockNews.com downgraded shares of Stericycle from a "buy" rating to a "hold" rating in a research report on Tuesday, April 2nd. Truist Financial raised their price objective on shares of Stericycle from $50.00 to $57.00 and gave the stock a "hold" rating in a research report on Thursday, February 29th. Finally, Wells Fargo & Company boosted their price target on shares of Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $60.80.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.